Divisions of Gynecology and Reproductive Endocrinology and Infertility, Department of Obstetrics & Gynecology, and the Department of Surgery, Mayo Clinic, Rochester, Minnesota.
Corresponding author: Shannon K. Laughlin-Tommaso, MD, MPH, Division of Gynecology, Department of Obstetrics and Gynecology, 200 First Street SW, Rochester, MN 55905; email: [email protected].
Supported by grant number P50HS023418 from the Agency for Healthcare Research and Quality.
Financial Disclosure Dr. Laughlin-Tommaso received personal fees from Allergan and grants from Halt Medical outside the submitted work. Dr. Stewart received personal fees from AbbVie, Allergan, Astellas, Bayer, GlaxoSmithKline, Gynesonics, Myovant, and Welltwigs outside the submitted work.
Continuing medical education for this article is available at https://links.lww.com/AOG/B129.
Each author has indicted that she has met the journal's requirements for authorship.